- Home
- BBGI vs SNSE Comparison
BBGI vs SNSE Comparison
Compare BBGI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- SNSE
- Stock Information
- Founded
- BBGI 1961
- SNSE 2005
- Country
- BBGI United States
- SNSE United States
- Employees
- BBGI N/A
- SNSE N/A
- Industry
- BBGI Broadcasting
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- SNSE Health Care
- Exchange
- BBGI Nasdaq
- SNSE Nasdaq
- Market Cap
- BBGI 10.0M
- SNSE 11.2M
- IPO Year
- BBGI 2000
- SNSE 2021
- Fundamental
- Price
- BBGI N/A
- SNSE N/A
- Analyst Decision
- BBGI
- SNSE Strong Buy
- Analyst Count
- BBGI 0
- SNSE 4
- Target Price
- BBGI N/A
- SNSE $72.50
- AVG Volume (30 Days)
- BBGI 50.5K
- SNSE 7.3K
- Earning Date
- BBGI 11-04-2025
- SNSE 11-13-2025
- Dividend Yield
- BBGI N/A
- SNSE N/A
- EPS Growth
- BBGI N/A
- SNSE N/A
- EPS
- BBGI N/A
- SNSE N/A
- Revenue
- BBGI $227,387,784.00
- SNSE N/A
- Revenue This Year
- BBGI $5.02
- SNSE N/A
- Revenue Next Year
- BBGI N/A
- SNSE N/A
- P/E Ratio
- BBGI N/A
- SNSE N/A
- Revenue Growth
- BBGI N/A
- SNSE N/A
- 52 Week Low
- BBGI $3.67
- SNSE $5.00
- 52 Week High
- BBGI $14.95
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- BBGI 59.90
- SNSE 73.13
- Support Level
- BBGI $5.21
- SNSE $9.35
- Resistance Level
- BBGI $5.75
- SNSE $10.00
- Average True Range (ATR)
- BBGI 0.37
- SNSE 0.48
- MACD
- BBGI -0.02
- SNSE 0.16
- Stochastic Oscillator
- BBGI 36.37
- SNSE 100.00
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).